1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for
Study
1.2.3.
Key Market
Segmentations
2. Research Methodology
2.1. Objective
of the Study
2.2. Baseline
Methodology
2.3. Key
Industry Partners
2.4. Major
Association and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data
Triangulation & Validation
2.7. Assumptions
and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Global Chronic
Idiopathic Constipation Therapeutic Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Class (Bulk-Forming Agents, Emollients, Laxatives,
Osmotic Agents)
5.2.2. By Route of
Administration (Oral, Parenteral)
5.2.3. By Distribution
Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
5.2.4.
By Region
5.2.5. By Company (2022)
5.3. Product Market Map
5.3.1. By Drug Class
5.3.2. By Route of Administration
5.3.3. By Distribution Channel
5.3.4. By Region
6.
North America Chronic
Idiopathic Constipation Therapeutic Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Class
(Bulk-Forming Agents, Emollients, Laxatives, Osmotic Agents)
6.2.2. By Route of
Administration (Oral, Parenteral)
6.2.3. By Distribution Channel (Hospital Pharmacies, Retail
Pharmacies, Online Pharmacies)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Chronic Idiopathic Constipation Therapeutic
Market Outlook
6.3.1.1.
Market Size &
Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share &
Forecast
6.3.1.2.1.
By Drug Class
6.3.1.2.2.
By Route of
Administration
6.3.1.2.3.
By Distribution
Channel
6.3.2. Canada Chronic Idiopathic Constipation Therapeutic Market Outlook
6.3.2.1.
Market Size &
Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share &
Forecast
6.3.2.2.1.
By Drug Class
6.3.2.2.2.
By Route of
Administration
6.3.2.2.3.
By Distribution
Channel
6.3.3. Mexico Chronic Idiopathic Constipation Therapeutic
Market Outlook
6.3.3.1.
Market Size &
Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share &
Forecast
6.3.3.2.1.
By Drug Class
6.3.3.2.2.
By Route of
Administration
6.3.3.2.3.
By Distribution
Channel
7.
Europe Chronic
Idiopathic Constipation Therapeutic Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Class
(Bulk-Forming Agents, Emollients, Laxatives, Osmotic Agents)
7.2.2. By Route of
Administration (Oral, Parenteral)
7.2.3. By Distribution Channel (Hospital Pharmacies, Retail
Pharmacies, Online Pharmacies)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Chronic Idiopathic Constipation Therapeutic Market Outlook
7.3.1.1.
Market Size &
Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share &
Forecast
7.3.1.2.1.
By Drug Class
7.3.1.2.2.
By Route of
Administration
7.3.1.2.3.
By Distribution
Channel
7.3.2. United Kingdom Chronic Idiopathic Constipation
Therapeutic Market Outlook
7.3.2.1.
Market Size &
Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share &
Forecast
7.3.2.2.1.
By Drug Class
7.3.2.2.2.
By Route of
Administration
7.3.2.2.3.
By Distribution
Channel
7.3.3. France Chronic Idiopathic Constipation Therapeutic Market Outlook
7.3.3.1.
Market Size &
Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share &
Forecast
7.3.3.2.1.
By Drug Class
7.3.3.2.2.
By Route of
Administration
7.3.3.2.3.
By Distribution
Channel
7.3.4. Italy Chronic Idiopathic Constipation Therapeutic Market Outlook
7.3.4.1.
Market Size &
Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share &
Forecast
7.3.4.2.1.
By Drug Class
7.3.4.2.2.
By Route of
Administration
7.3.4.2.3.
By Distribution
Channel
7.3.5. Spain Chronic Idiopathic Constipation Therapeutic Market Outlook
7.3.5.1.
Market Size &
Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share &
Forecast
7.3.5.2.1.
By Drug Class
7.3.5.2.2.
By Route of
Administration
7.3.5.2.3.
By Distribution
Channel
8.
Asia-Pacific Chronic
Idiopathic Constipation Therapeutic Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Class
(Bulk-Forming Agents, Emollients, Laxatives, Osmotic Agents)
8.2.2. By Route of
Administration (Oral, Parenteral)
8.2.3. By Distribution Channel (Hospital Pharmacies, Retail
Pharmacies, Online Pharmacies)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Chronic Idiopathic Constipation Therapeutic Market Outlook
8.3.1.1.
Market Size &
Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share &
Forecast
8.3.1.2.1.
By Drug Class
8.3.1.2.2.
By Route of
Administration
8.3.1.2.3.
By Distribution
Channel
8.3.2. Japan Chronic Idiopathic Constipation Therapeutic Market Outlook
8.3.2.1.
Market Size &
Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share &
Forecast
8.3.2.2.1.
By Drug Class
8.3.2.2.2.
By Route of
Administration
8.3.2.2.3.
By Distribution
Channel
8.3.3. India Chronic Idiopathic Constipation Therapeutic Market Outlook
8.3.3.1.
Market Size &
Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share &
Forecast
8.3.3.2.1.
By Drug Class
8.3.3.2.2.
By Route of
Administration
8.3.3.2.3.
By Distribution
Channel
8.3.4. Australia Chronic Idiopathic Constipation Therapeutic Market Outlook
8.3.4.1.
Market Size &
Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share &
Forecast
8.3.4.2.1.
By Drug Class
8.3.4.2.2.
By Route of
Administration
8.3.4.2.3.
By Distribution
Channel
8.3.5. South Korea Chronic Idiopathic Constipation Therapeutic Market Outlook
8.3.5.1.
Market Size &
Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share &
Forecast
8.3.5.2.1.
By Drug Class
8.3.5.2.2.
By Route of
Administration
8.3.5.2.3.
By Distribution
Channel
9.
South America Chronic
Idiopathic Constipation Therapeutic Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Class
(Bulk-Forming Agents, Emollients, Laxatives, Osmotic Agents)
9.2.2. By Route of
Administration (Oral, Parenteral)
9.2.3. By Distribution Channel (Hospital Pharmacies, Retail
Pharmacies, Online Pharmacies)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Chronic Idiopathic Constipation Therapeutic Market Outlook
9.3.1.1.
Market Size &
Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share &
Forecast
9.3.1.2.1.
By Drug Class
9.3.1.2.2.
By Route of
Administration
9.3.1.2.3.
By Distribution
Channel
9.3.2. Argentina Chronic Idiopathic Constipation Therapeutic Market Outlook
9.3.2.1.
Market Size &
Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share &
Forecast
9.3.2.2.1.
By Drug Class
9.3.2.2.2.
By Route of
Administration
9.3.2.2.3.
By Distribution
Channel
9.3.3. Colombia Chronic Idiopathic Constipation Therapeutic Market Outlook
9.3.3.1.
Market Size &
Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share &
Forecast
9.3.3.2.1.
By Drug Class
9.3.3.2.2.
By Route of
Administration
9.3.3.2.3.
By Distribution
Channel
10.
Middle East and
Africa Chronic Idiopathic Constipation Therapeutic Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1. By Drug Class
(Bulk-Forming Agents, Emollients, Laxatives, Osmotic Agents)
10.2.2. By Route of
Administration (Oral, Parenteral)
10.2.3. By Distribution Channel (Hospital Pharmacies, Retail
Pharmacies, Online Pharmacies)
10.2.4. By Country
10.3.
MEA: Country
Analysis
10.3.1. South Africa Chronic Idiopathic Constipation Therapeutic Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Drug Class
10.3.1.2.2.
By Route of
Administration
10.3.1.2.3.
By Distribution
Channel
10.3.2. Saudi Arabia Chronic Idiopathic Constipation Therapeutic Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Drug Class
10.3.2.2.2.
By Route of
Administration
10.3.2.2.3.
By Distribution
Channel
10.3.3. UAE Chronic Idiopathic Constipation Therapeutic Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Drug Class
10.3.3.2.2.
By Route of
Administration
10.3.3.2.3.
By Distribution
Channel
10.3.4. Kuwait Chronic Idiopathic Constipation Therapeutic Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1.
By Drug Class
10.3.4.2.2.
By Route of
Administration
10.3.4.2.3.
By Distribution
Channel
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Recent Development
12.2.
Mergers &
Acquisitions
12.3.
Product Launches
13.
Porter’s Five Forces Analysis
13.1.
Competition in the
Industry
13.2.
Potential of New Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute
Products
14. Competitive Landscape
14.1.
Business Overview
14.2.
Product Offerings
14.3.
Recent Developments
14.4.
Financials (As Reported)
14.5.
Key Personnel
14.6.
SWOT Analysis
14.6.1. GSK PLC
14.6.2. Astellas Pharma Inc
14.6.3. Synergy Pharmaceuticals Inc.
14.6.4. Bayer AG
14.6.5. Allergan PLC
14.6.6. Sanofi SA
14.6.7. Pfizer Inc
14.6.8. Takeda Pharmaceutical Co Ltd
14.6.9. Zydus Lifesciences Ltd
14.6.10.
Boehringer Ingelheim GmbH
15. Strategic Recommendations
16.
About Us & Disclaimer